Abpro Alternatives & Competitors
12 companies similar to Abpro — Developing antibody therapies to improve the lives of patients facing severe and...
Companies similar to Abpro
Merus N.V.
Merus was acquired by Genmab. To see what’s new, visit Genmab.
Utrecht, The Netherlands
RemedyBio
Remedy is creating a revolution in immune therapeutics though cell-by-cell analysis of imm...
Dublin, Ireland
Inhibrx Biosciences, Inc.
Innovation Focused Outcomes Driven
San Diego, United States
FK Biotecnologia
Pioneering biomedical innovation with advanced biotech solutions since 1999.
Rival Readout
Competing with Abpro ? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
MacroGenics, Inc.
Developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious disea...
Rockville, United States
BiosPacific
Manufacturer and supplier of antibodies and antigens of exceptional quality, to the IVD ma...
Emeryville, United States
Biotheus Inc.
To Inspire Each Other and Create Effective Medicines for Humankind
Zhuhai, China
Ichor Biologics
Accelerating cures for infectious diseases
New York, United States
AMSBIO
AMSBIO is a global supplier of research products and custom services for biological and ph...
Abingdon, United Kingdom
-logo.jpg "Protein Alternatives SL (PROALT)"){kind=logo}
Protein Alternatives SL (PROALT)
Proteins and antibodies applied to health
Tres Cantos, Spain
Y-Biologics
Exploring antibodies, creating novel therapeutics
Daejeon, Korea South
About Abpro
Abpro is a biotech company that is dedicated to advancing antibody therapeutics for severe diseases. With a focus on immuno-oncology and ophthalmology, the company leverages its proprietary DiversImmune® and MultiMab platforms to develop next-gen antibodies. Collaborating with global pharmaceutical and research partner...
Antibody Therapeutics, Immuno-Oncology, Ophthalmology, Reagents, Biochemistry, Recombinant Proteins, Collaborations, Therapeutic Antibodies, Cancer Research, Infectious Diseases, T-Cell Engagers, Wet AMD, DME, Bi-Specific Antibodies
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Abpro : 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Abpro on 13 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
